Insite Vision Inc.  

(Public, OTCMKTS:INSV)   Watch this stock  
Find more results for 303, Inc
0.190
+0.010 (5.56%)
Apr 17 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.17 - 0.20
52 week 0.15 - 0.35
Open 0.17
Vol / Avg. 65,360.00/154,380.00
Mkt cap 25.07M
P/E 4.38
Div/yield     -
EPS 0.04
Shares 131.95M
Beta 1.13
Inst. own 29%
May 5, 2014
Q1 2014 InSite Vision Incorporated Earnings Release (Estimated) Add to calendar
Mar 27, 2014
Insite Vision Q4 and Year-End 2013 Financial Results Conference Call - Webcast
Mar 27, 2014
Q4 2013 InSite Vision Incorporated Earnings Release
  

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -467.51% 18.76%
Operating margin -237.92% 42.52%
EBITD margin - 42.87%
Return on average assets -120.91% 36.22%
Return on average equity - -
Employees 31 -
CDP Score - -

Address

965 ATLANTIC AVE
ALAMEDA, CA 94501
United States - Map
+1-510-8658800 (Phone)
+1-510-8655700 (Fax)

Website links

Description

InSite Vision Incorporated (InSite) is an ophthalmic product development company advancing ophthalmic pharmaceutical products to address unmet eye care needs. The Company's current portfolio of products is based on the Company's DuraSite sustained drug delivery technology. Its DuraSite sustained drug delivery technology is a synthetic polymer-based formulation designed to extend the residence time of a drug relative to conventional topical therapies. It enables topical delivery of a drug as a solution, gel or suspension and can be customized for delivering a wide variety of drug candidates. The Company is focused its research and development and commercial support efforts on the topical products formulated with its DuraSite drug delivery technology. It may also utilize its DuraSite technology platform for the formulation of new ocular product candidates using either non drugs or compounds developed by others for non-ophthalmic indications.

Officers and directors

Timothy McInerney Independent Chairman of the Board
Age: 52
Timothy M. Ruane Chief Executive Officer, Director
Age: 48
Louis C. Drapeau CPA Chief Financial Officer, Vice President
Age: 69
Surendra Patel Vice President - Operations & Quality
Age: 57
Lyle M. Bowman Ph.D. Vice President - Development
Age: 64
Kamran Hosseini M.D., Ph.D. Chief Medical Officer, Vice President - Clinical & Regulatory Affairs
Age: 48
Brian Levy O.D Independent Director
Age: 61
Robert O'Holla Independent Director
Age: 61
Craig A. Tooman Independent Director
Age: 48
Anthony J. Yost Independent Director
Age: 54